Verition Fund Management
BIIB icon

Verition Fund Management’s Biogen BIIB Stock Holding History

Verition Fund Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-160,000
Closed -$21.9M – 3640
2025
Q1 		$21.9M Hold
160,000
– – 0.1% 188
2024
Q4 		$24.5M Buy
160,000
+152,100
+1,925% +$25.7M 0.1% 177
2024
Q3 		$1.53M Hold
7,900
– – 0.01% 1593
2024
Q2 		$1.83M Sell
7,900
-1,100
-12% -$239K 0.01% 1322
2024
Q1 		$1.94M Buy
9,000
+4,100
+84% +$960K 0.01% 1228
2023
Q4 		$1.27M Sell
4,900
-200
-4% -$49.1K 0.01% 1055
2023
Q3 		$1.31M Buy
+5,100
New +$1.36M 0.02% 960
2022
Q4 		– Sell
-3,500
Closed -$935K – 2166
2022
Q3 		$935K Buy
+3,500
New +$743K 0.01% 1450
2022
Q2 		– Sell
-2,600
Closed -$548K – 2377
2022
Q1 		$548K Buy
+2,600
New +$565K 0.01% 1857
2021
Q4 		– Sell
-2,700
Closed -$764K – 2544
2021
Q3 		$764K Buy
+2,700
New +$885K 0.01% 1046

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Verition Fund Management's BIIB Position: Q2 2026 in Review

Verition Fund Management opened a new position in Biogen (BIIB) in Q2 2026: 30,914 shares worth $6.68M. The stake represents 0.03% of the portfolio and ranks #523 among its holdings. This is a return to the name: Verition Fund Management previously reported a position in BIIB as recently as Q4 2025.

Verition Fund Management first reported a position in BIIB in Q2 2013 and has held it in 42 quarters since. The position peaked at $54.5M in Q3 2023. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Verition Fund Management held 30,914 shares of Biogen worth $6.68M as of Q2 2026.
  • Biogen was a new Verition Fund Management position in Q2 2026.
  • Biogen made up 0.03% of Verition Fund Management's portfolio in Q2 2026, its #523 holding.
  • Verition Fund Management first reported a position in Biogen in Q2 2013 and has held it in 42 quarters since.
  • Verition Fund Management's Biogen position peaked at $54.5M in Q3 2023.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.